Generalized myasthenia gravis
Clinical trials for Generalized myasthenia gravis explained in plain language.
Never miss a new study
Get alerted when new Generalized myasthenia gravis trials appear
Sign up with your email to follow new studies for Generalized myasthenia gravis, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New CAR-T therapy aims to calm overactive immune system in muscle weakness disease
Disease control Not yet recruitingThis early study tests a new treatment called HN2301 in 6 adults with generalized myasthenia gravis, a disease that causes muscle weakness. The treatment uses the body's own immune cells to target and reduce harmful immune activity. The main goal is to check safety and see how we…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase 1 • Sponsor: Shenzhen MagicRNA Biotechnology Co., Ltd • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
Engineered immune cells take aim at debilitating muscle weakness
Disease control Not yet recruitingThis early-phase trial tests a single infusion of universal STAR-T cells—engineered immune cells—in adults aged 18 to 65 with refractory generalized myasthenia gravis, a condition causing severe muscle weakness. The study aims to assess safety, tolerability, and signs of effectiv…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase 1 • Sponsor: Daishi Tian • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
New hope for myasthenia gravis patients: experimental drug enters phase 2 trial
Disease control Not yet recruitingThis study tests whether SHR-2173, added to usual care, improves symptoms of generalized myasthenia gravis (gMG) better than a placebo. About 60 adults with confirmed gMG will receive the drug or placebo for 24 weeks. The main goal is to see if daily muscle weakness and fatigue s…
Matched conditions: GENERALIZED MYASTHENIA GRAVIS
Phase 2 • Sponsor: Guangdong Hengrui Pharmaceutical Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC